Publications

Search our bibliography using the filters on the right-hand side.

Displaying 301 through 350 of 350 publications.

Neighbors D, Irish WD, Lopez R, Degen K, Swann A, Grogg A. Inpatient medication utilization and costs of risperidone, olanzapine, and quetiapine: a retrospective chart abstraction study. Poster presented at the 2002 ISPOR 7th Annual International Meeting; May 19, 2002. Arlington, VA. [abstract] Value Health. 2002 May; 5(3):234.

Niaura R, Shadel WG, Britt DM, Abrams DB. Response to social stress, urge to smoke, and smoking cessation. Addict Behav. 2002 Mar 1;27(2):241-50.

Cid Ruzafa J, Arana A, Rueda de Castro AM, Warner BA, Kumar V, O'Sullivan D. Effective prevention of clozaril granulocyte toxicity. Presented at the XII World Congress of Psychiatry; March 2002.

Longo CJ, Raskin J, Gilsenan AW, Corey-Lisle P, Sherrill EH, Hopkins JS. Prevalence of treatment-resistant depression in Saskatchewan—limitations of a claims based analysis. Poster presented at the XXIII CINP Congress; 2002.

Odom DM, Stivers J. The effects of September 11th on unit nonresponse in the national survey on drug use and health. Poster presented at the American Association for Public Opinion Research; 2002.

Gilsenan AW, Hopkins JS, Sherrill EH, Corey-Lisle PK, Longo CJ, Raskin J. Prevalence and costs of treatment-resistant depression in a Canadian claims database. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; 2002.

Pendergast KB, Gilsenan AW, West SL, Swindle RW, Kroenke K. Differences in psychological and other quality of life dimensions in depressed patients identified as low-risk or high-risk for suicide. Poster presented at the 18th International Conference on Pharmacoepidemiology; 2002.

Packer L, Odom DM, Chromy J, Davis T, Gfroerer J. Changes in NHSDA measures of substance use initiation. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.185-220.

Hopkins JS, Gilsenan AW, Sherrill EH, Cory-Lisle PK, Longo CJ, Raskin J. Methods to identify treatment-resistant depression in a Canadian claims database. Poster presented at the International Society for Pharmacoepidemiology Conference; 2002.

Eyerman J, Odom DM, Wu S, Butler D. Nonresponse in the 1999 NHSDA. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.23-51.

Hughes A, Chromy J, Giacoletti K, Odom DM. Impact of interviewer experience on respondent reports of substance use.. In: Gfroerer J, Eyerman J, Chromy J, editors. Redesigning an ongoing national household survey: methodological issues. Rockville: United States. DHHS; 2002. p.161-84.

Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R, Weinberger M. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 2001 Dec 19;286(23):2947-55.

Ellison RC, Zhang Y, McLennan CE, Rothman KJ. Exploring the relation of alcohol consumption to risk of breast cancer. Am J Epidemiol. 2001 Oct 15;154(8):740-7.

Britt DM, Cohen LM, Collins FL, Cohen ML. Cigarette smoking and chewing gum: response to a laboratory-induced stressor. Health Psychol. 2001 Sep 1;20(5):361-8.

Hollifield MH, Midkiff KD, Warner T. Reliability and validity of the comprehensive trauma inventory and the New Mexico refugee symptom checklist. Poster presented at the Society for the Study of Psychiatry and Culture; September 2001.

Midkiff KD, Hollifield MH. Phase II methods: the epidemiology of torture and trauma in two refugee populations. Poster presented at the University of New Mexico Dept. of Psychiatry; September 2001. Albuquerque, NM.

Alexeyeva I, Mauskopf JA, Earnshaw SR, Gibson JP, Ascher-Svanum H, Ramsey J. A model comparing olanzapine and ziprasidone in patients with schizophrenia. Poster presented at the 2001 ISPOR 6th Annual International Meeting; May 2001. [abstract] Value Health. 2001 Sep; 4(2):148-9.

McLeod LD, Fehnel SE. An application: evaluating the psychometric properties of the acne-qol within the context of a randomized, placebo-controlled study. Poster presented at the annual meeting of the Psychometric Society; July 2001.

DePyssler B, Williams VS, Windle M. African American college student alcohol consumption: the role of positive study practices. Alcohol Clin Exp Res. 2001 Jun;25(5):90A.

Dixon-Roman E, Williams VS, Witherspoon D, Green M, Windle M. African American college student alcohol consumption: the role of ethnic identity. Alcohol Clin Exp Res. 2001 Jun;25(5):90A.

Bauman KE, Foshee VA, Ennett ST, Pemberton M, Hicks KA, King TS, Koch GG. The influence of a family program on adolescent tobacco and alcohol use. Am J Public Health. 2001 Apr 1;91(4):604-10.

Britt DM, Petrie CD, Cappelleri JC. Effect size tables for the Nottingham health profile, the psychological general well-being, and the medical outcomes study short-form survey (SF-36). Poster presented at the Worldwide Outcomes Research Forum, Pfizer Global Outcomes Research; April 2001. Miami, FL.

McKenna SP, Doward LC, Kohlmann T, Mercier C, Niero M, Paes M, Patrick D, Ramirez N, Thorsen H, Whalley D. International development of the Quality of Life in Depression Scale (QLDS). J Affect Disord. 2001 Mar 1;63(1-3):189-99.

Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001 Mar 1;15(1):13-7.

David SP, Niaura RS, Britt DM, Shadel WG, Walton RT, Murphy M. A genetic role for bupropion in smoking cessation. Poster presented at the 7th Annual Meeting of the Society for Research on Nicotine and Tobacco; March 2001.

Ennett ST, Bauman KE, Foshee VA, Pemberton M, Hicks KA. Parent-child communication about adolescent tobacco and alcohol use: what do parents say and does it affect youth behavior? J Marriage Fam. 2001 Feb 1;63(1):48-62.

Bauman KE, Foshee VA, Ennett ST, Hicks K, Pemberton M. Family matters: a family-directed program designed to prevent adolescent tobacco and alcohol use. Health Promot Pract. 2001 Jan 1;2(1):81-96.

Williams VS, Ellison T, Witherspoon D, Dixon-Romain E, MacKinnon D, Green M. African American college student alcohol consumption: using focus groups and cognitive testing to develop a multimedia student alcohol survey. Alcohol Clin Exp Res. 2001;25(5):91A.

Alexeyeva I, Mauskopf J, Earnshaw SR, Stauffer VL, Gibson JP, Ascher-Svanum H. Comparing olanzapine and ziprasidone in the treatment of schizophrenia: a case study in modeling. J Med Econ. 2001 Jan 1;4:179-92.

Cook SA, Doward LC, McKenna SP, Erdman R, Niero M, van Assche D. Venous leg ulcers – patient-reported impact on quality of life. Proc Br Psychol Soc. 2001;9(1):64.

Green M, Williams VS, Witherspoon D, Dixon-Roman E, Windle M. African American college student alcohol consumption: the role of religiosity and spirituality. Alcohol Clin Exp Res. 2001;25(5):90A.

Dewar AL, Doward LC, Whalley D, McKenna SP, Tennant A, Emery P. Impact of systemic lupus erythematosus (SLE) experienced from the patients' perspective. Proc Br Psychol Soc. 2001;9(1):64.

King TK, Britt DM, Lloyd E. Demographic and psychological characteristics of obese smokers presenting for weight loss treatment. Ann Behav Med. 2001;23(Suppl):S027.

Pendergast KB, West SL, Gilsenan AW, Swindle R, Kroenke K. Development of a suicidal assessment algorithm for telephone interviewers. Poster presented at the 16th International Conference on Pharmacoepidemiology; August 2000.

McKenna SP, Whalley D, Doward LC. Which outcomes are important in schizophrenia? Int J Methods Psychiatr Res. 2000;9(1):S58-67.

Patsula LN, McLeod LD. Detecting items that have been memorized in computerized-adaptive testing and multi-stage testing: a comparison. Poster presented at the annual meeting of the National Council on Measurement in Education; 2000.

Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry. 1999 Dec;175:575-80. doi: 10.1192/bjp.175.6.576

Ennett ST, Bauman K, Foshee VA, Pemberton M, Hicks KA. Family communication about adolescent tobacco and alcohol use. Presented at the American Public Health Association annual meeting; November 1999.

Niaura R, Britt DM, Borrelli B, Shadel WG, Abrams DB, Goldstein MG. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res. 1999 Sep 1;1(3):251-7.

Odom DM, Kalsbeek W. Further analysis of call history from the behavioral risk factor surveillance system. Poster presented at the Proceedings of the American Statistical Association, Section of Survey Research Methods; 1999. Alexandria, VA.

McLeod LD, Lewis C. Detecting item memorization in the CAT environment. Appl Psychol Meas. 1999 Jan 1;23(2):147-60.

McKenna SP, Whalley D. Can quality of life scales tell us when patients begin to feel the benefits of antidepressants? Eur Psychiatry. 1998 May;13(3):146-53.

Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology. 1997 Nov 1;8(6):671-7.

Knox D, Gibson L, Zusman ME, Gallmeier C. Why college students end relationships. Coll Stud J. 1997 Jan 1;31(4):449-52.

Johannes CB, Avis NE. Comparison of gender differences in factors related to depression in mid-aged adults. Presented at the American Psychological Association Annual Meeting; 1996. Washington, DC.

Whalley D, McKenna SP. Measuring quality of life in patients with depression or anxiety. Pharmacoeconomics. 1995 Oct;8(4):305-15.

Godding PR, McAnulty RD, Wittrock DA, Britt DM, Khansur T. Predictors of depression among male cancer patients. J Nerv Ment Dis. 1995 Feb 1;183(2):95-8.

French MT, Bradley CJ, Calingaert B, Dennis ML, Karuntzos GT. Cost analysis of training and employment services in methadone treatment. Eval Program Plann. 1994 Apr 1;17(2):107-20.

Rothman KJ. The proportion of cancer attributable to alcohol-consumption. Prev Med. 1980 Mar 1;9(2):174-9.

Rothman KJ. Persons at high risk of cancer. An approach to cancer etiology and control. In: Fraumeni J Jr, editor, editors. Alcohol. New York: NY. Academic Press; 1975.